affiliates. All Rights Reserved.
Page 2 of 2
References:
1. D.A.A. Mossel, et al., J. Bact. 84, 381 (1962)
2. D.A.A. Mossel, et al., J. Appl. Bact. 26, 444 (1963)
3. D.A.A.
Methods Enzymol., 70(A), 419-439
(1980).
2. Jones, J.V. et al., J. Immunol. Methods, 118(1), 79-
84 (1989).
3. Voller, A., and Bidwell, D., “Enzyme-linked
immunoabsorbent assay”, in Manual of Clinical
References
1. Voller, A. et al., Bull. World Health Organ., 53(1),
55-65 (1976).
2. Jones, J.V. et al., J. Immunol. Methods, 118(1), 79-
84 (1989).
3. Bahouth, S.W., “Development of Antibodies to
exceeded 85% with average rela-
tive standard deviation (RSD) of 4.7%. The other 9 compounds
had recovery between 70% to 84%, with average RSD of 7.8%.
Together, 98 of 102 compounds in this study have the
OMeMeO
855-38-9 395102
68 PCy2Ph
P
6476-37-5 288284
69 Dicyclohexyl(4-(N,N-dimethylamino)
phenyl)phosphine
N
P
40438-64-0 692689
79 P(iPr)3
P
6476-36-4 377309
84 PallylPh2
P